Replies to post #217742 on Biotech Values

[Whalatane]

ESPR ...and then theres this ...probably why stock sold off

https://www.bloomberg.com/gadfly/articles/2018-03-07/esperion-s-good-bempedolic-acid-trial-results-aren-t-enough

Kiwi

[north40000]

Personally, I seem in better shape/ results with Amarin and its Vascepa—see post # 117234 on AMRN board. Much less expensive too at $9/month.